1966
DOI: 10.1016/s0140-6736(66)90303-5
|View full text |Cite
|
Sign up to set email alerts
|

Steroid Therapy and Strongyloidiasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0
1

Year Published

1967
1967
2016
2016

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(18 citation statements)
references
References 10 publications
0
17
0
1
Order By: Relevance
“…[14][15][16][17][18] Risk factors for dissemination are shown in Box 1. Details of these mechanisms remain unclear, as there are have been cases of hyperinfection in people with no identifiable immunodeficiency.…”
Section: Risk Factors For Disseminationmentioning
confidence: 99%
“…[14][15][16][17][18] Risk factors for dissemination are shown in Box 1. Details of these mechanisms remain unclear, as there are have been cases of hyperinfection in people with no identifiable immunodeficiency.…”
Section: Risk Factors For Disseminationmentioning
confidence: 99%
“…7 The present patient was also not in an immunosuppressed condition, except that he had taken corticosteroid intermittently for his gouty arthritis for approximately 20 years, with average doses of 30 mg prednisolone every 2 months. The intermittent steroid treatment may be associated with the development of pericardial Strongyloidiasis, 8 although he was not ever on long-term steroid therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Some authors believe that the urticaria ofstronglyloidiasis may be due to an allergic reaction to the protease secreted by the larva rather than to the larva per se. Our case suggests that even low doses of steroids may alter the host parasite equilibrium lead ing to a suppression of the inflammatory and immunologic response [9,10]. …”
mentioning
confidence: 81%